Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?
ACS Omega · 28.03.2023 · 8 (12) · 10713-10746
DOI: 10.1021/acsomega.2c07326 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ACS Omega, online erschienen am 13.03.2023. Verfasst von Mangala Hegde und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India. Die Arbeit wurde bisher 316-mal zitiert (Crossref) und nennt 314 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Engineering Research Board, Department of Biotechnology , Ministry of Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India.
ORCID-Profile: Ravichandran Vishwa, Ajaikumar B Kunnumakkara
Förderung
- Science and Engineering Research Board
- Department of Biotechnology , Ministry of Science and Technology
Zitieren
APA
Hegde, M., Girisa, S., BharathwajChetty, B., Vishwa, R., & Kunnumakkara, A. B. (2023). Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?. ACS Omega, 8(12), 10713-10746. https://doi.org/10.1021/acsomega.2c07326
Vancouver
Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?. ACS Omega. 2023;8(12):10713-10746. doi:10.1021/acsomega.2c07326
BibTeX
@article{Hegde2023,
author = {Hegde, Mangala and Girisa, Sosmitha and BharathwajChetty, Bandari and Vishwa, Ravichandran and Kunnumakkara, Ajaikumar B},
title = {Curcumin Formulations for Better Bioavailability: What We Learned from Clinical Trials Thus Far?},
journal = {ACS Omega},
year = {2023},
volume = {8},
number = {12},
pages = {10713--10746},
doi = {10.1021/acsomega.2c07326}
}
EUVIMED